Inhalable Drugs Market Size, Share, Applications by 2028

Inhalable drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 38.32 billion by 2028 and will grow at a CAGR of 5.65% in the above mentioned forecast period.

Inhalable drugs are broadly used for treating chronic diseases such as COPD, bronchospasm, and asthma and non-respiratory diseases such as diabetes and Parkinson's disease. Medicines that one breathes directly into lungs are an essential part of treatment for the lungs. Various combinations of inhaled drugs are used to heal many lung diseases, counting asthma and chronic obstructive pulmonary diseases (COPD).

The increasing prevalence of non-respiratory diseases such as Parkinson’s disease and diabetes is among the essential factors that intensify the inhalable drugs market's growth and demand. The rising geriatric population and advancements in inhalable drug therapies are also contributing to rising in the global market over the forecast period of 2021 to 2028. Also, the growing popularity of the procedure owing to its advantages over the oral and parenteral drug administration such as direct injection into the body or bypassing the skin and mucous membranes is also enhancing the market's growth.

Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-inhalable-drugs-market

North America region leads the inhalable drugs market owing to the easy availability of advanced products and growing awareness programs by the government and major players within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rising disposable income and escalating investment in the healthcare sector by various government and non-governmental bodies in this particular region.

The major players covered in the inhalable drugs market report are AstraZeneca, Sanofi, Vectura Group plc, Avalyn Pharma, Mylan N.V., Quotient Sciences, Alaxia, EffRx Pharmaceuticals SA, GlaxoSmithKline Plc, Merck & Co., Inc., TFF PHARMACEUTICALS, INC., Catalent, Inc, IRISYS, LLC, Teicos Pharma Ltd, Nelson Laboratories, LLC, Intertek Group plc, Mundipharma International, Pharmaxis Ltd., Boehringer Ingelheim International GmbH and Cipla Inc., among other domestic and global players.

Related Reports:

Global Hyperoxaluria drug market https://www.databridgemarketresearch.com/reports/global-hyperoxaluria-drug-market

Global Topical Non-Steroidal Anti-Inflammatory Drugs Market https://www.databridgemarketresearch.com/reports/global-topical-non-steroidal-anti-inflammatory-drugs-market

Global Muscle Relaxant Drugs Market https://www.databridgemarketresearch.com/reports/global-muscle-relaxant-drugs-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact: 

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Health-Fitness/44926-Inhalable-Drugs-Market-Size-Share-Applications-by-2028.html